Antibiotics susceptibility patterns of Citrobacter freundii isolated from pa-tients with urinary tract infection in Al-Najaf governorate – Iraq

Author:

Thualfakar Hayder ,Ahmed Abdul Jabbar Jaloob Aljanaby

Abstract

Citrobacter freundii is one of the most causative agents of urinary tract infection in human due to their high antimicrobials resistance. Therefore, this study aimed to evaluate the ability of Citrobacter freundii to resist to fifteen antimicrobials. A total of 461 urine samples were collected from patients infected with urinary tract infection, females and males, age groups between 18 to 60 years old performed in Al-Najaf central hospital in Al-Najaf City, Iraq, during April to December 2018. Antimicrobials susceptibility testing was performed by disc diffusion method according to the Kirby-Bauer method onto Mueller Hinton agar surface. There were 30 isolates (6.5%) diagnosed as Citrobacter freundii. Antimicrobial resistance rate of the 30 isolates to Amoxicillin and Chloramphenicol were all high (25 isolates 83.4%), Ciprofloxacin, Streptomycin and Sulfonamide (24 isolates 80%). The good resistance rate was observed for Penicillin, Amoxiclav and Ceftazidime (21 isolates 70%). The moderate resistance rate was observed for Cefotaxime (19 isolates 63.3%), Ceftriaxone (20 isolates 66.7%), Gentamicin (15 isolates 50%), Tobramycin (18 isolates 60%) and Erythromycin (20 isolates 66.7%). The lowest resistance rate was observed for Tetracycline (19 isolates 63.3%). While Imipenem provided full antibacterial activity (30 isolates 100%). Of the total 30 isolates, 22 (73.3%) were multi-drug resistance, 8(26.7%) extensive-drug resistance and no isolates were pan-drug resistance. While 19 isolates (63.3%) were extended-spectrum beta-lactamase producing Citrobacter freundii. Citrobacter freundii has highly resistant against most antimicrobials and became more dangerous bacteria cause urinary tract infection.

Publisher

GP Innovations Pvt. Ltd.

Subject

General Pharmacology, Toxicology and Pharmaceutics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3